198 related articles for article (PubMed ID: 30139236)
1. Differential Expression of RAGE, EGFR and Ki-67 in Primary Tumors and Lymph Node Deposits of Breast Carcinoma.
Aboushousha T; Hammam O; Safwat G; Eesa A; Ahmed S; Esmat ME; Helmy AH
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2269-2277. PubMed ID: 30139236
[TBL] [Abstract][Full Text] [Related]
2. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 expression in axillary lymph node metastases in breast cancer is prognostically significant.
Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
Hum Pathol; 2013 Jan; 44(1):39-46. PubMed ID: 22939959
[TBL] [Abstract][Full Text] [Related]
4. The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer.
Koda M; Sulkowska M; Kanczuga-Koda L; Tomaszewski J; Kucharczuk W; Lesniewicz T; Cymek S; Sulkowski S
Oncol Rep; 2007 Jul; 18(1):113-9. PubMed ID: 17549355
[TBL] [Abstract][Full Text] [Related]
5. Axillary Skip Metastases and the False-Negative Rate of Sentinel Lymph Node Biopsy in Patients With Breast Cancer Are Related to Negative ALDH-1 Expression and Ki-67 Expression.
Kim WG; Lee J
Int J Surg Pathol; 2017 Aug; 25(5):397-405. PubMed ID: 28145149
[TBL] [Abstract][Full Text] [Related]
6. MCQs on "Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes".
Darling HS; Jayalakshmi S; Jaiswal P
Indian J Cancer; 2020; 57(2):198-200. PubMed ID: 32445324
[No Abstract] [Full Text] [Related]
7. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
8. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes.
Arun B; Kilic G; Yen C; Foster B; Yardley D; Gaynor R; Ashfaq R
Cancer; 2003 Dec; 98(12):2554-9. PubMed ID: 14669273
[TBL] [Abstract][Full Text] [Related]
9. Androgen and androgen-metabolizing enzymes in metastasized lymph nodes of breast cancer.
Shibahara Y; Miki Y; Sakurada C; Uchida K; Hata S; McNamara K; Yoda T; Takagi K; Nakamura Y; Suzuki T; Ishida T; Ohuchi N; Sasano H
Hum Pathol; 2013 Oct; 44(10):2338-45. PubMed ID: 23953348
[TBL] [Abstract][Full Text] [Related]
10. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
11. EGFR, c-erbB2 and p53 protein in the primary lesions and paired metastatic regional lymph nodes in breast cancer.
Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
Eur J Surg Oncol; 2002 Jun; 28(4):383-7. PubMed ID: 12099646
[TBL] [Abstract][Full Text] [Related]
12. Common protein biomarkers assessed by reverse phase protein arrays show considerable intratumoral heterogeneity in breast cancer tissues.
Malinowsky K; Raychaudhuri M; Buchner T; Thulke S; Wolff C; Höfler H; Becker KF; Avril S
PLoS One; 2012; 7(7):e40285. PubMed ID: 22792263
[TBL] [Abstract][Full Text] [Related]
13. Association of the involvement of axillary lymph nodes in HER-2/neu overexpression in patients with breast cancer.
Ziaeemehr A; Shahidsales S; Ghosi Z; Avan A; Aldavood AS; Anvari K; Makhdoomi Y; Asadi M
Breast J; 2019 May; 25(3):537-538. PubMed ID: 30973656
[No Abstract] [Full Text] [Related]
14. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
Falck AK; Fernö M; Bendahl PO; Rydén L
World J Surg; 2010 Jul; 34(7):1434-41. PubMed ID: 20213203
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of computed tomography perfusion in assessing metastatic involvement of enlarged axillary lymph nodes in patients with breast cancer.
Liu Y; Bellomi M; Gatti G; Ping X
Breast Cancer Res; 2007; 9(4):R40. PubMed ID: 17615058
[TBL] [Abstract][Full Text] [Related]
16. Association between tumor size and immunohistochemical expression of Ki-67, p53 and BCL2 in a node-negative breast cancer population selected from a breast cancer screening program.
González-Sistal A; Sánchez AB; Del Rio MC; Arias JI; Herranz M; Ruibal A
Anticancer Res; 2014 Jan; 34(1):269-73. PubMed ID: 24403473
[TBL] [Abstract][Full Text] [Related]
17. Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer.
van Agthoven T; Timmermans M; Dorssers LC; Henzen-Logmans SC
Int J Cancer; 1995 Dec; 63(6):790-3. PubMed ID: 8847135
[TBL] [Abstract][Full Text] [Related]
18. Predictive parameters for internal mammary node drainage in patients with early breast cancer.
Lukesova L; Vrana D; Gatek J; Koranda P; Cwiertka K; Radova L; Melichar B; Prouzova Z; Sramek V; Svach I
Tumori; 2014; 100(3):254-8. PubMed ID: 25076234
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53.
Bassarova AV; Nesland JM; Sedloev T; Lilleby W; Hristova SL; Trifonov DY; Torlakovic E
Int J Surg Pathol; 2005 Jul; 13(3):239-46. PubMed ID: 16086078
[TBL] [Abstract][Full Text] [Related]
20. Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases.
Nogami T; Shien T; Tanaka T; Nishiyama K; Mizoo T; Iwamto T; Ikeda H; Taira N; Doihara H; Miyoshi S
Breast Cancer; 2014 Jan; 21(1):58-65. PubMed ID: 22407396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
